Primary record
4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone BMS-536924
- 库存
- 5,519 克
- 纯度
- 99.1 %
- CAS
- 468740-43-4
化合物标识与属性
- CAS
- 468740-43-4
- PubChem CID
- 135440466
- SMILES
- CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@H](C4=CC(=CC=C4)Cl)O)N5CCOCC5
- Canonical SMILES
- Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12
名称与同义词
- BMS-536924
- 468740-43-4
- CDK inhibitor
- BMS536924
- 40E3AZG1MX
- BMS 536924
- UNII-40E3AZG1MX
- RefChem:917422
- C25H26ClN5O3
- D0M4SY
- CHEMBL401930
- cc-534
- MLS006011171
- Insulin-like Growth Factor-1 Receptor Inhibitor
- orb1300786
- SCHEMBL4132577
- SCHEMBL15974144
- SCHEMBL29157676
- SCHEMBL29402692
- SCHEMBL30540371
- SCHEMBL30753554
- BDBM27879
- CHEBI:91454
- UGQMURPIMYALPH-KKPVDXMRSA-N
- DTXSID201352325
- GLXC-03510
- BCP02116
- EX-A4566
- ZINC6718468
- 2278AH
- ABP000159
- MFCD20278190
- NSC761760
- s1012
- TP-808
- BMS 536924 [WHO-DD]
- AKOS024458339
- AKOS025149514
- ZINC140935730
- ACN-039827
- ACN-039828
- CCG-269544
- CS-0117
- KIN001-126
- NSC-761760
- RL03740
- CID10390396
- CID11353973
- NCGC00346460-02
- NCGC00346460-04
- NCGC00346460-05
- NCGC00346460-06
- AC-32997
- AS-78828
- CID 11353973
- DA-71582
- HY-10262
- SMR004702940
- CID:135440466
- SID:316619344
- BMS-536924/BMS536924
- A2238
- SW218124-2
- X5078
- 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone
- J2.568.805H
- A11054
- D94990
- S-7752
- (S)-4-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)-3-(4-methyl-6-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one
- BMS-536924, >=98% (HPLC)
- A872226
- C504983
- BRD-K34581968-001-01-2
- BRD-K34581968-001-04-6
- BRD-K34581968-001-05-3
- Q27163296
- Q27258319
- B1370-142616
- 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one
- (3M)-4-{[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-3-[4-methyl-6-(morpholin-4-yl)-1H-benzimidazol-2-yl]pyridin-2(1H)-one
- 4-{[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-3-[7-methyl-5-(morpholin-4-yl)-1H-1,3-benzodiazol-2-yl]-1,2-dihydropyridin-2-one
- (S)-4-((2-(3-CHLOROPHENYL)-2-HYDROXYETHYL)AMINO)-3-(4-METHYL-6-MORPHOLINO-1H-BENZO(D)IMIDAZOL-2-YL)PYRIDIN-2(1H)-ONE
- (s)-4-[2-(3-chloro-phenyl)-2-hydroxy-ethylamino]-3-(4-methyl-6-morpholin-4-yl-1h-benzoimidazol-2-yl)-1h-pyridin-2-one
- 129830-38-2
- 2(1H)-PYRIDINONE, 4-(((2S)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL)AMINO)-3-(7-METHYL-5-(4-MORPHOLINYL)-1H-BENZIMIDAZOL-2-YL)-
- 3-(5-Morpholino-7-methyl-1H-benzoimidazole-2-yl)-4-[[(S)-beta-hydroxy-3-chlorophenethyl]amino]-1,2-dihydropyridine-2-one
- 4-(((2S)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL)AMINO)-3-(7-METHYL-5-(4-MORPHOLINYL)-1H-BENZIMIDAZOL-2-YL)-2(1H)-PYRIDINONE
- 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxy-ethyl]amino]-3-(4-methyl-6-morpholino-1H-benzimidazol-2-yl)-1H-pyridin-2-one
- 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-morpholinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-pyridinone
- 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone BMS-536924
- 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone;
- 4-{[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino}-3-[4-methyl-6-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone
- 4-{[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-3-[4-methyl-6-(morpholin-4-yl)-1H-1,3-benzodiazol-2-yl]-1,2-dihydropyridin-2-one
- 4-{[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-3-[4-methyl-6-(morpholin-4-yl)-1H-1,3-benzodiazol-2-yl]-1H-pyridin-2-one
- 4-{[(2S)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL]AMINO}-3-[4-METHYL-6-(MORPHOLIN-4-YL)-3H-1,3-BENZODIAZOL-2-YL]-1H-PYRIDIN-2-ONE
- N6I